Login Register Cart 0
Generic placeholder image

Recent Advances in Inflammation & Allergy Drug Discovery

Editor-in-Chief

ISSN (Print): 2772-2708
ISSN (Online): 2772-2716

Back
Journal Home About Journal Editorial Board Current Issue Volumes/Issues
Subscribe
Review Article

Modulation of the Immune System Mechanisms using Probiotic Bacteria in Allergic Diseases: Focus on Allergic Retinitis and Food Allergies

Author(s): Haleh Forouhandeh, Saiedeh Razi Soofiyani, Kamran Hosseini, Sohrab Minaei Beirami, Hossein Ahangari, Yusif Moammer, Sara Ebrahimzadeh, Masoomeh Kashef Nejad, Afsaneh Farjami*, Fariba Khodaiefar* and Vahideh Tarhriz*

Volume 18, Issue 1, 2024

Published on: 11 October, 2023

Page: [11 - 26] Pages: 16

DOI: 10.2174/0127722708246899230928080651

Price: $65

conference banner
Abstract

Allergic illnesses occur when an organism's immune system is excessively responsive to certain antigens, such as those that are presented in the environment. Some people suffer from a wide range of immune system-related illnesses including allergic rhinitis, asthma, food allergies, hay fever, and even anaphylaxis. Immunotherapy and medications are frequently used to treat allergic disorders. The use of probiotics in bacteriotherapy has lately gained interest. Probiotics are essential to human health by modulating the gut microbiota in some ways. Due to probiotics' immunomodulatory properties present in the gut microbiota of all animals, including humans, these bacterial strains can prevent a wide variety of allergic disorders. Probiotic treatment helps allergy patients by decreasing inflammatory cytokines and enhancing intestinal permeability, which is important in the battle against allergy. By altering the balance of Th1 and Th2 immune responses in the intestinal mucosa, probiotics can heal allergic disorders. Numerous studies have shown a correlation between probiotics and a reduced risk of allergy disorders. A wide range of allergic disorders, including atopic dermatitis, asthma, allergic retinitis and food allergies has been proven to benefit from probiotic bacteria. Therefore, the use of probiotics in the treatment of allergic diseases offers a promising perspective. Considering that probiotic intervention in the treatment of diseases is a relatively new field of study, more studies in this regard seem necessary.

« Previous Next »
Graphical Abstract

[1]
Douglass JA, O’Hehir RE. 1. Diagnosis, treatment and prevention of allergic disease: The basics. Med J Aust 2006; 185(4): 228-33.
[http://dx.doi.org/10.5694/j.1326-5377.2006.tb00539.x] [PMID: 16922672]
[2]
Pawankar R. WAO White Book on Allergy: World Allergy Organization. Philadelphia: Lippincott 2011.
[3]
Kay AB. Allergy and allergic diseases. First of two parts. N Engl J Med 2001; 344(1): 30-7.
[http://dx.doi.org/10.1056/NEJM200101043440106] [PMID: 11136958]
[4]
Spacova I, Ceuppens JL, Seys SF, Petrova MI, Lebeer S. Probiotics against airway allergy: Host factors to consider. Dis Model Mech 2018; 11(7): dmm034314.
[http://dx.doi.org/10.1242/dmm.034314] [PMID: 30037806]
[5]
Maldonado Galdeano C, Cazorla SI, Lemme Dumit JM, Vélez E, Perdigón G. Beneficial effects of probiotic consumption on the immune system. Ann Nutr Metab 2019; 74(2): 115-24.
[http://dx.doi.org/10.1159/000496426] [PMID: 30673668]
[6]
Il’ina N. Allergic rhinitis. Aller Asthma Clin Immunol 2024; 4: 2024.
[7]
Sicherer SH, Sampson HA. Food allergy: Epidemiology, pathogenesis, diagnosis, and treatment. J All Clin Immunol 2014; 133(2): 291-307.e5.
[http://dx.doi.org/10.1016/j.jaci.2013.11.020]
[8]
Frieri M. Mast cell activation syndrome. Clin Rev Allergy Immunol 2018; 54(3): 353-65.
[http://dx.doi.org/10.1007/s12016-015-8487-6] [PMID: 25944644]
[9]
Frew AJ. Allergen immunotherapy. J Allergy Clin Immunol 2010; 125(2) (Suppl. 2): S306-13.
[http://dx.doi.org/10.1016/j.jaci.2009.10.064] [PMID: 20176266]
[10]
Forouhandeh H. Evaluation of the cytotoxic activity of anthriscus nemorosa on breast cancer cells. J Contemporary Med Sci 2021; 7(4): 217-26.
[11]
Asgharian P, Quispe C, Herrera-Bravo J, et al. Pharmacological effects and therapeutic potential of natural compounds in neuropsychiatric disorders: An update. Front Pharmacol 2022; 13: 926607.
[http://dx.doi.org/10.3389/fphar.2022.926607] [PMID: 36188551]
[12]
Huang YJ, Marsland BJ, Bunyavanich S, et al. The microbiome in allergic disease: Current understanding and future opportunities-2017 practall document of the american academy of allergy, asthma & immunology and the european academy of allergy and clinical immunology. J Allergy Clin Immunol 2017; 139(4): 1099-110.
[http://dx.doi.org/10.1016/j.jaci.2017.02.007] [PMID: 28257972]
[13]
Forouhandeh H. Phenotypic and phylogenetic characterization of Lactobacillus species isolated from traditional Lighvan cheese. Food Production. Proc Nutr 2021; 3(1): 1-9.
[14]
Eslami M, Bahar A, Keikha M, Karbalaei M, Kobyliak NM, Yousefi B. Probiotics function and modulation of the immune system in allergic diseases. Allergol Immunopathol (Madr) 2020; 48(6): 771-88.
[http://dx.doi.org/10.1016/j.aller.2020.04.005] [PMID: 32763025]
[15]
Fiocchi A, Cabana MD, Mennini M. Current use of probiotics and prebiotics in allergy. J Allergy Clin Immunol Pract 2022; 10(9): 2219-42.
[http://dx.doi.org/10.1016/j.jaip.2022.06.038] [PMID: 35792336]
[16]
Ebrahimi V, Tarhriz V, Talebi M, et al. A new insight on feasibility of pre-, pro-, and synbiotics-based therapies in Alzheimer’s disease. J Reports Pharmaceut Sci 2022; 11(2): 141.
[http://dx.doi.org/10.4103/jrptps.JRPTPS_170_21]
[17]
Gaggìa F, Mattarelli P, Biavati B. Probiotics and prebiotics in animal feeding for safe food production. Int J Food Microbiol 2010; 141 (Suppl. 1): S15-28.
[http://dx.doi.org/10.1016/j.ijfoodmicro.2010.02.031] [PMID: 20382438]
[18]
Steiner NC, Lorentz A. Probiotic potential of Lactobacillus species in allergic rhinitis. Int Arch Allergy Immunol 2021; 182(9): 807-18.
[http://dx.doi.org/10.1159/000515352] [PMID: 33882482]
[19]
Barzegari A, Kheyrolahzadeh K, Hosseiniyan Khatibi SM, Sharifi S, Memar MY, Zununi Vahed S. The battle of probiotics and their derivatives against biofilms. Infect Drug Resist 2020; 13: 659-72.
[http://dx.doi.org/10.2147/IDR.S232982] [PMID: 32161474]
[20]
Canny GO, McCormick BA. Bacteria in the intestine, helpful residents or enemies from within? Infect Immun 2008; 76(8): 3360-73.
[http://dx.doi.org/10.1128/IAI.00187-08] [PMID: 18474643]
[21]
Abreu MT, Fukata M, Arditi M. TLR signaling in the gut in health and disease. J Immunol 2005; 174(8): 4453-60.
[http://dx.doi.org/10.4049/jimmunol.174.8.4453] [PMID: 15814663]
[22]
Toh ZQ, Anzela A, Tang MLK, Licciardi PV. Probiotic therapy as a novel approach for allergic disease. Front Pharmacol 2012; 3: 171.
[http://dx.doi.org/10.3389/fphar.2012.00171] [PMID: 23049509]
[23]
Gu S, Yang D, Liu C, Xue W. The role of probiotics in prevention and treatment of food allergy. Food Sci Hum Wellness 2023; 12(3): 681-90.
[http://dx.doi.org/10.1016/j.fshw.2022.09.001]
[24]
Huang J, Zhang J, Wang X, et al. Effect of probiotics on respiratory tract allergic disease and gut microbiota. Front Nutr 2022; 9: 821900.
[http://dx.doi.org/10.3389/fnut.2022.821900] [PMID: 35295917]
[25]
Lopez-Santamarina A, Gonzalez EG, Lamas A, Mondragon AC, Regal P, Miranda JM. Probiotics as a possible strategy for the prevention and treatment of allergies. A narrative review. Foods 2021; 10(4): 701.
[http://dx.doi.org/10.3390/foods10040701] [PMID: 33806092]
[26]
Abul Abbas AL. Cellular and Molecular Immunology. Elsevier 2016.
[27]
Michael E. Genetic polymorphisms and associated susceptibility to asthma. Int J Gen Med 2013; 6: 253-65.
[28]
Bruce S. Advances in mechanisms of allergy and clinical immunology. J Allergy Clin Immunol 2012; 131(3): 661-7.
[29]
Michail S. The role of Probiotics in allergic diseases. Allergy Asthma Clin Immunol 2009; 5(1): 5.
[http://dx.doi.org/10.1186/1710-1492-5-5]
[30]
Cebra JJ. Influences of microbiota on intestinal immune system development. Am J Clin Nutr 1999; 69(5): 1046S-51S.
[http://dx.doi.org/10.1093/ajcn/69.5.1046s]
[31]
Noah W. Immune-microbiota interactions in health and disease. Clin Immunol 2016; 159(2): 122-7.
[32]
Thomas DJ, Husmann RJ, Villamar M, Winship TR, Buck RH, Zuckermann FA. Lactobacillus rhamnosus HN001 attenuates allergy development in a pig model. PLoS One 2011; 6(2): e16577.
[http://dx.doi.org/10.1371/journal.pone.0016577]
[33]
Wang HF, Tseng CY, Chang MH, et al. Antiinflammatory effects of probiotic Lactobacillus paracasi on ventricles of BALB/C mice treated with ovalbumin. Chin J Physiol 2012; 55(1): 37-46.
[34]
de Azevedo SI. Immunotherapy of allergic diseases using probiotics or recombinant probiotics. J Appl Microbiol 2013; 115(2): 319-3.
[35]
Marko Kalliomäki J-MA. Guidance for substantiating the evidence for beneficial effects of probiotics: Prevention and management of allergic diseases by probiotics. J Nutr 2010; 140(3): 713S-21S.
[36]
Im GSaS-H. Probiotics as a potential immunomodulating pharmabiotics in allergic diseases: Current status and future prospects. Allergy Asthma Immunol Res 2018; 10(6): 575-90.
[37]
Ozdemir O. Prebiotics and probiotics in allergy: Potential mechanisms of prebiotics’ and probiotics’ actions in allergy-(Part 1). MOJ Immunol 2016; 3(1): 00069.
[http://dx.doi.org/10.15406/moji.2016.03.00069]
[38]
Johansson SG, Bieber T, Dahl R, et al. Revised nomenclature for allergy for global use: Report of the nomenclature review committee of the world allergy organization, October 2003. J Allergy Clin Immunol 2004; 113(5): 832-6.
[http://dx.doi.org/10.1016/j.jaci.2003.12.591] [PMID: 15131563]
[39]
Prioult G, Nagler-Anderson C. Mucosal immunity and allergic responses: Lack of regulation and/or lack of microbial stimulation? Immunol Rev 2005; 206(1): 204-18.
[http://dx.doi.org/10.1111/j.0105-2896.2005.00277.x] [PMID: 16048551]
[40]
Tang RB, Chang JK, Chen HL. Can probiotics be used to treat allergic diseases? J Chin Med Assoc 2015; 78(3): 154-7.
[http://dx.doi.org/10.1016/j.jcma.2014.08.015] [PMID: 25575754]
[41]
Bloemen K, Verstraelen S, Van Den Heuvel R, Witters H, Nelissen I, Schoeters G. The allergic cascade: Review of the most important molecules in the asthmatic lung. Immunol Lett 2007; 113(1): 6-18.
[http://dx.doi.org/10.1016/j.imlet.2007.07.010] [PMID: 17765979]
[42]
Xystrakis E, Boswell SE, Hawrylowicz CM. T regulatory cells and the control of allergic disease. Expert Opin Biol Ther 2006; 6(2): 121-33.
[http://dx.doi.org/10.1517/14712598.6.2.121] [PMID: 16436038]
[43]
Akdis M, Blaser K, Akdis CA. T regulatory cells in allergy: Novel concepts in the pathogenesis, prevention, and treatment of allergic diseases. J Allergy Clin Immunol 2005; 116(5): 961-8.
[http://dx.doi.org/10.1016/j.jaci.2005.09.004] [PMID: 16275361]
[44]
Akdis M, Verhagen J, Taylor A, et al. Immune responses in healthy and allergic individuals are characterized by a fine balance between allergen-specific T regulatory 1 and T helper 2 cells. J Exp Med 2004; 199(11): 1567-75.
[http://dx.doi.org/10.1084/jem.20032058] [PMID: 15173208]
[45]
Ling EM, Smith T, Nguyen XD, et al. Relation of CD4+CD25+ regulatory T-cell suppression of allergen-driven T-cell activation to atopic status and expression of allergic disease. Lancet 2004; 363(9409): 608-15.
[http://dx.doi.org/10.1016/S0140-6736(04)15592-X] [PMID: 14987885]
[46]
Karlsson MR, Rugtveit J, Brandtzaeg P. Allergen-responsive CD4+CD25+ regulatory T cells in children who have outgrown cow’s milk allergy. J Exp Med 2004; 199(12): 1679-88.
[http://dx.doi.org/10.1084/jem.20032121] [PMID: 15197226]
[47]
Yang J, Kuang H, Li N, Hamdy AM, Song J. The modulation and mechanism of probiotic-derived polysaccharide capsules on the immune response in allergic diseases. Crit Rev Food Sci Nutr 2022; 1-13.
[http://dx.doi.org/10.1080/10408398.2022.2062294] [PMID: 35400262]
[48]
Larché M. Regulatory T cells in allergy and asthma. Chest 2007; 132(3): 1007-14.
[http://dx.doi.org/10.1378/chest.06-2434] [PMID: 17873195]
[49]
Averina OV, Poluektova EU, Marsova MV, Danilenko VN. Biomarkers and utility of the antioxidant potential of probiotic Lactobacilli and Bifidobacteria as representatives of the human gut microbiota. Biomedicines 2021; 9(10): 1340.
[http://dx.doi.org/10.3390/biomedicines9101340] [PMID: 34680457]
[50]
Wang X, Zhang P, Zhang X. Probiotics regulate gut microbiota: An effective method to improve immunity. Molecules 2021; 26(19): 6076.
[http://dx.doi.org/10.3390/molecules26196076] [PMID: 34641619]
[51]
Shimizu K, Ojima M, Ogura H. Gut microbiota and probiotics/synbiotics for modulation of immunity in critically ill patients. Nutrients 2021; 13(7): 2439.
[http://dx.doi.org/10.3390/nu13072439] [PMID: 34371948]
[52]
Morris P, Ali K, Merritt M, Pelletier J, Macedo LG. A systematic review of the role of inflammatory biomarkers in acute, subacute and chronic non-specific low back pain. BMC Musculoskelet Disord 2020; 21(1): 142.
[http://dx.doi.org/10.1186/s12891-020-3154-3] [PMID: 32126991]
[53]
Lomax A, Calder P. Probiotics, immune function, infection and inflammation: A review of the evidence from studies conducted in humans. Curr Pharm Des 2009; 15(13): 1428-518.
[http://dx.doi.org/10.2174/138161209788168155] [PMID: 19442167]
[54]
Salles BIM, Cioffi D, Ferreira SRG. Probiotics supplementation and insulin resistance: A systematic review. Diabetol Metab Syndr 2020; 12(1): 98.
[http://dx.doi.org/10.1186/s13098-020-00603-6] [PMID: 33292434]
[55]
Zavišić G, Ristić S, Rikalović M. et al. Beneficial effects of probiotic supplementation on glucose and triglycerides in a mouse mod
[http://dx.doi.org/10.1016/j.jff.2022.105167]
[56]
Hoffmann A, Kleniewska P, Pawliczak R. Antioxidative activity of probiotics. Arch Med Sci 2021; 17(3): 792-804.
[http://dx.doi.org/10.5114/aoms.2019.89894] [PMID: 34025850]
[57]
Zamani B, Sheikhi A, Namazi N, Larijani B, Azadbakht L. The effects of supplementation with probiotic on biomarkers of oxidative stress in adult subjects: A systematic review and meta-analysis of randomized trials. Probiotics Antimicrob Proteins 2020; 12(1): 102-11.
[http://dx.doi.org/10.1007/s12602-018-9500-1] [PMID: 30666617]
[58]
Mishra V, Shah C, Mokashe N, Chavan R, Yadav H, Prajapati J. Probiotics as potential antioxidants: A systematic review. J Agric Food Chem 2015; 63(14): 3615-26.
[http://dx.doi.org/10.1021/jf506326t] [PMID: 25808285]
[59]
Dissanayake E, Inoue Y. MicroRNAs in allergic disease. Curr Allergy Asthma Rep 2016; 16(9): 67.
[http://dx.doi.org/10.1007/s11882-016-0648-z] [PMID: 27585977]
[60]
Specjalski K, Jassem E. MicroRNAs: potential biomarkers and targets of therapy in allergic diseases? Arch Immunol Ther Exp 2019; 67(4): 213-23.
[http://dx.doi.org/10.1007/s00005-019-00547-4] [PMID: 31139837]
[61]
Weidner J, Bartel S, Kılıç A. et al. Spotlight on microRNAs in allergy and asthma. Allergy 2021; 76(6): 1661-78.
[http://dx.doi.org/10.1111/all.14646] [PMID: 33128813]
[62]
Rebane A. microRNA and allergy. In: microRNA: Medical Evidence Advances in Experimental Medicine and Biology. Cham: Springer 2015; 888: 331-52.
[63]
Wang J, Zhou Y, Zhang H, et al. Pathogenesis of allergic diseases and implications for therapeutic interventions. Signal Transduct Target Ther 2023; 8(1): 138.
[http://dx.doi.org/10.1038/s41392-023-01344-4] [PMID: 36964157]
[64]
van de Veen W, Akdis M. The use of biologics for immune modulation in allergic disease. J Clin Invest 2019; 129(4): 1452-62.
[http://dx.doi.org/10.1172/JCI124607] [PMID: 30882368]
[65]
Alberto Caminero MM. Mechanisms by which gut microorganisms influence food sensitivities. Nat Rev Gastroenterol Hepatol 2018; 16(1): 7-18.
[66]
Rudolf V, Heidrun H. Food allergies: The basics. Gastroenterology 2015; 148(6): 1120-31.e4.
[67]
Anna Maria C, Chiara V, Silvia C, et al. Probiotics and food allergy. Ital J Pediatr 2013; 39: 47.
[68]
Zhang GQ, Hu HJ, Liu CY, Zhang Q, Shakya S, Li ZY. Probiotics for prevention of atopy and food hypersensitivity in early childhood: A PRISMA-compliant systematic review and meta-analysis of randomized controlled trials. Medicine 2016; 95(8): e2562.
[http://dx.doi.org/10.1097/MD.0000000000002562] [PMID: 26937896]
[69]
Elazab N, Mendy A, Gasana J, Vieira ER, Quizon A, Forno E. Probiotic administration in early life, atopy, and asthma: A meta-analysis of clinical trials. Pediatrics 2013; 132(3): e666-76.
[http://dx.doi.org/10.1542/peds.2013-0246] [PMID: 23958764]
[70]
Wickens K, Black P, Stanley TV, et al. A protective effect of Lactobacillus rhamnosus HN001 against eczema in the first 2 years of life persists to age 4 years. Clin Exp Allergy 2012; 42(7): 1071-9.
[http://dx.doi.org/10.1111/j.1365-2222.2012.03975.x] [PMID: 22702506]
[71]
Rautava S, Kainonen E, Salminen S, Isolauri E. Maternal probiotic supplementation during pregnancy and breast-feeding reduces the risk of eczema in the infant. J Allergy Clin Immunol 2012; 130(6): 1355-60.
[http://dx.doi.org/10.1016/j.jaci.2012.09.003] [PMID: 23083673]
[72]
Wong Yu DMHF, Kari C. Food allergy: immune mechanisms, diagnosis and immunotherapy. Nat Rev Immunol 2017; 16(12): 751-65.
[73]
Sjögren YM. Altered early infant gut microbiota in children developing allergy up to 5 years of age. Clin Exp Allergy 2009; 39(4): 518-26.
[74]
JinghuaZhong X. The gut microbiome-immune axis as a target for nutrition-mediated modulation of food allergy. Trends Food Sci Technol 2021; 114: 116-32.
[75]
Reid G. Probiotics and prebiotics - Progress and challenges. Int Dairy J 2008; 18(10-11): 969-75.
[http://dx.doi.org/10.1016/j.idairyj.2007.11.025]
[76]
MacDonald TT, Monteleone G. Immunity, inflammation, and allergy in the gut. Science 2005; 307(5717): 1920-5.
[http://dx.doi.org/10.1126/science.1106442] [PMID: 15790845]
[77]
Paveljšek D, Ivičak-Kocjan K, Treven P, Benčina M, Jerala R, Rogelj I. Distinctive probiotic features share common TLR2 dependent signalling in intestinal epithelial cells. Cell Microbiol 2021; 23(1): e13264.
[http://dx.doi.org/10.1111/cmi.13264] [PMID: 32945079]
[78]
Kanmani P, Kim H. Beneficial effect of immunobiotic strains on attenuation of Salmonella induced inflammatory response in human intestinal epithelial cells. PLoS One 2020; 15(3): e0229647.
[http://dx.doi.org/10.1371/journal.pone.0229647] [PMID: 32150574]
[79]
Rescigno M, Urbano M, Valzasina B, et al. Dendritic cells express tight junction proteins and penetrate gut epithelial monolayers to sample bacteria. Nat Immunol 2001; 2(4): 361-7.
[http://dx.doi.org/10.1038/86373] [PMID: 11276208]
[80]
Hart AL, Lammers K, Brigidi P, et al. Modulation of human dendritic cell phenotype and function by probiotic bacteria. Gut 2004; 53(11): 1602-9.
[http://dx.doi.org/10.1136/gut.2003.037325] [PMID: 15479680]
[81]
Ghavami SB, Yadegar A, Aghdaei HA, et al. Immunomodulation and generation of tolerogenic dendritic cells by probiotic bacteria in patients with inflammatory bowel disease. Int J Mol Sci 2020; 21(17): 6266.
[http://dx.doi.org/10.3390/ijms21176266] [PMID: 32872480]
[82]
Engevik MA, Ruan W, Esparza M, et al. Immunomodulation of dendritic cells by Lactobacillus reuteri surface components and metabolites. Physiol Rep 2021; 9(2): e14719.
[http://dx.doi.org/10.14814/phy2.14719] [PMID: 33463911]
[83]
Hacer YAPICIO, ĞLU Y. Probiyotikler ve çocuklarda bağışıklık sistemi. Klinik Tıp Pediatri Dergisi 2016; 8(3): 5-10.
[84]
Rocha-Ramírez L. Probiotic Lactobacillus strains stimulate the inflammatory response and activate human macrophages. J Immunol Res 2017; 2017: 4607491.
[85]
Kaila M. Enhancement of the circulating antibody secreting cell response in human diarrhea by a human lactobacillus strain. Pediatr Infect Dis J 1993; 12(3): 263.
[http://dx.doi.org/10.1097/00006454-199303000-00027]
[86]
Fu Linglin. Yogurt-sourced probiotic bacteria alleviate shrimp tropomyosin-induced allergic mucosal disorders, potentially through microbiota and metabolism modifications. Allergol Int 2019; 68(4): 506-14.
[87]
Gabriella Di F. Use of probiotic bacteria for prevention and therapy of allergic diseases: studies in mouse model of allergic sensitization. J Clin Gastroenterol 2008; 42 (Suppl 3 Pt 1): S130-2.
[88]
Kuitunen M. Probiotics and prebiotics in preventing food allergy and eczema. Curr Opin Allergy Clin Immunol 2013; 13(3): 280-6.
[http://dx.doi.org/10.1097/ACI.0b013e328360ed66]
[89]
De Vrese M. Probiotics, prebiotics, and synbiotics. Adv Biochem Eng Biotechnol 2008; 111: 1-66.
[90]
Chukeatirote E. Potential use of probiotics. Songklanakarin J Sci Technol 2003; 25(2): 275-82.
[91]
Asahara T, Shimizu K, Nomoto K, Hamabata T, Ozawa A, Takeda Y. Probiotic bifidobacteria protect mice from lethal infection with Shiga toxin-producing Escherichia coli O157:H7. Infect Immun 2004; 72(4): 2240-7.
[http://dx.doi.org/10.1128/IAI.72.4.2240-2247.2004] [PMID: 15039348]
[92]
Ouwehand AC, Salminen S, Tölkkö S, Roberts P, Ovaska J, Salminen E. Resected human colonic tissue: new model for characterizing adhesion of lactic acid bacteria. Clin Diagn Lab Immunol 2002; 9(1): 184-6.
[PMID: 11777852]
[93]
Van Tassell ML, Miller MJ. Lactobacillus adhesion to mucus. Nutrients 2011; 3(5): 613-36.
[http://dx.doi.org/10.3390/nu3050613] [PMID: 22254114]
[94]
Buck BL, Altermann E, Svingerud T, Klaenhammer TR. Functional analysis of putative adhesion factors in Lactobacillus acidophilus NCFM. Appl Environ Microbiol 2005; 71(12): 8344-51.
[http://dx.doi.org/10.1128/AEM.71.12.8344-8351.2005] [PMID: 16332821]
[95]
Hynönen U, Westerlund-Wikström B, Palva A, Korhonen TK. Identification by flagellum display of an epithelial cell- and fibronectin-binding function in the SlpA surface protein of Lactobacillus brevis. J Bacteriol 2002; 184(12): 3360-7.
[http://dx.doi.org/10.1128/JB.184.12.3360-3367.2002] [PMID: 12029053]
[96]
Todorov SD, Furtado DN, Saad SM, Gombossy de Melo Franco BD. Bacteriocin production and resistance to drugs are advantageous features for Lactobacillus acidophilus La-14, a potential probiotic strain. New Microbiol 2011; 34(4): 357-70.
[PMID: 22143809]
[97]
Yildirim Z, Winters DK, Johnson MG. Purification, amino acid sequence and mode of action of bifidocin B produced by Bifidobacterium bifidum NCFB 1454. J Appl Microbiol 1999; 86(1): 45-54.
[http://dx.doi.org/10.1046/j.1365-2672.1999.00629.x] [PMID: 10030011]
[98]
Qian Z. Antibacterial activity of lactobacillus strains isolated from Mongolian yogurt against Gardnerella vaginalis. Biomed Res Int 2020; 2020: 3548618.
[http://dx.doi.org/10.1155/2020/3548618]
[99]
Igbafe J, Kilonzo-Nthenge A, Nahashon SN, Mafiz AI, Nzomo M. Probiotics and antimicrobial effect of Lactiplantibacillus plantarum, Saccharomyces cerevisiae, and Bifidobacterium longum against common foodborne pathogens in poultry. Agriculture 2020; 10(9): 368.
[http://dx.doi.org/10.3390/agriculture10090368]
[100]
Hummel S, Veltman K, Cichon C, Sonnenborn U, Schmidt MA. Differential targeting of the E-Cadherin/β-Catenin complex by gram-positive probiotic lactobacilli improves epithelial barrier function. Appl Environ Microbiol 2012; 78(4): 1140-7.
[http://dx.doi.org/10.1128/AEM.06983-11] [PMID: 22179242]
[101]
Wang J, Ji H, Wang S, et al. Probiotic Lactobacillus plantarum promotes intestinal barrier function by strengthening the epithelium and modulating gut microbiota. Front Microbiol 2018; 9: 1953.
[http://dx.doi.org/10.3389/fmicb.2018.01953] [PMID: 30197632]
[102]
Sharifi S, Dizaj SM, Samiei M, et al. Application of collagen and mesenchymal stem cells in regenerative dentistry. Curr Stem Cell Res Ther 2022; 17(7): 606-20.
[http://dx.doi.org/10.2174/1574888X17666211220100521] [PMID: 34931969]
[103]
Hirano T. IL-6 in inflammation, autoimmunity and cancer. Int Immunol 2021; 33(3): 127-48.
[http://dx.doi.org/10.1093/intimm/dxaa078] [PMID: 33337480]
[104]
Fatmawati NND, Gotoh K, Mayura IPB, et al. Enhancement of intestinal epithelial barrier function by Weissella confusa F213 and Lactobacillus rhamnosus FBB81 probiotic candidates in an in vitro model of hydrogen peroxide-induced inflammatory bowel disease. BMC Res Notes 2020; 13(1): 489.
[http://dx.doi.org/10.1186/s13104-020-05338-1] [PMID: 33081842]
[105]
Babu PR. Prophylaxis of experimental food allergy with probiotic Lactococcus lactis. Int Immunol Meeting Abstract 2010; 22(S1 Pt 4): iv108-13.
[106]
Bianca B, Giacomo V. Probiotic VSL#3-induced TGF-β ameliorates food allergy inflammation in a mouse model of peanut sensitization through the induction of regulatory T cells in the gut mucosa. Mol Nutr Food Res 2013; 57(12): 2233-44.
[107]
Ogawa T, Asai Y, Tamai R, et al. Natural killer cell activities of synbiotic Lactobacillus casei ssp. casei in conjunction with dextran. Clin Exp Immunol 2005; 143(1): 103-9.
[http://dx.doi.org/10.1111/j.1365-2249.2005.02975.x] [PMID: 16367940]
[108]
Asher MI, Montefort S, Björkstén B, et al. Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC Phases One and Three repeat multicountry cross-sectional surveys. Lancet 2006; 368(9537): 733-43.
[http://dx.doi.org/10.1016/S0140-6736(06)69283-0] [PMID: 16935684]
[109]
Liu P, Hu T, Kang C, et al. Research advances in the treatment of allergic rhinitis by probiotics. J Asthma Allergy 2022; 15: 1413-28.
[http://dx.doi.org/10.2147/JAA.S382978] [PMID: 36238950]
[110]
Forouhandeh H, Tarhriz V, Zadehkamand M, Asgharian P. Anti-proliferative activity of Artemisia marschalliana on cancerous cell lines. BMC Complement Med Ther 2023; 23(1): 119.
[http://dx.doi.org/10.1186/s12906-023-03887-z] [PMID: 37059982]
[111]
Ishida Y, Nakamura F, Kanzato H, et al. Clinical effects of Lactobacillus acidophilus strain L-92 on perennial allergic rhinitis: A double-blind, placebo-controlled study. J Dairy Sci 2005; 88(2): 527-33.
[http://dx.doi.org/10.3168/jds.S0022-0302(05)72714-4] [PMID: 15653517]
[112]
Peng GC, Hsu CH. The efficacy and safety of heat-killed Lactobacillus paracasei for treatment of perennial allergic rhinitis induced by house-dust mite. Pediatr Allergy Immunol 2005; 16(5): 433-8.
[http://dx.doi.org/10.1111/j.1399-3038.2005.00284.x] [PMID: 16101937]
[113]
Yan F, Polk DB. Probiotics and immune health. Curr Opin Gastroenterol 2011; 27(6): 496-501.
[http://dx.doi.org/10.1097/MOG.0b013e32834baa4d] [PMID: 21897224]
[114]
Walker WA. Mechanisms of action of probiotics. Clin Infect Dis 2008; 46(s2) (Suppl. 2): S87-91.
[http://dx.doi.org/10.1086/523335] [PMID: 18181730]
[115]
Wang MF, Lin HC, Wang YY, Hsu CH. Treatment of perennial allergic rhinitis with lactic acid bacteria. Pediatr Allergy Immunol 2004; 15(2): 152-8.
[http://dx.doi.org/10.1111/j.1399-3038.2004.00156.x] [PMID: 15059192]
[116]
Giovannini M, Agostoni C, Riva E, et al. A randomized prospective double blind controlled trial on effects of long-term consumption of fermented milk containing Lactobacillus casei in pre-school children with allergic asthma and/or rhinitis. Pediatr Res 2007; 62(2): 215-20.
[http://dx.doi.org/10.1203/PDR.0b013e3180a76d94] [PMID: 17597643]
[117]
Hu B, Kuang Y, Jing Y, Li Y, Zhao H, Ouyang H. Pediatric allergic rhinitis with functional gastrointestinal disease: Associations with the intestinal microbiota and gastrointestinal peptides and therapeutic effects of interventions. Hum Exp Toxicol 2021; 40(11): 2012-21.
[http://dx.doi.org/10.1177/09603271211017325] [PMID: 34018444]
[118]
Kawase M, He F, Kubota A, et al. Effect of fermented milk prepared with two probiotic strains on Japanese cedar pollinosis in a double-blind placebo-controlled clinical study. Int J Food Microbiol 2009; 128(3): 429-34.
[http://dx.doi.org/10.1016/j.ijfoodmicro.2008.09.017] [PMID: 18977549]
[119]
Ouwehand AC, Nermes M, Collado MC, Rautonen N, Salminen S, Isolauri E. Specific probiotics alleviate allergic rhinitis during the birch pollen season. World J Gastroenterol 2009; 15(26): 3261-8.
[http://dx.doi.org/10.3748/wjg.15.3261] [PMID: 19598302]
[120]
Xiao JZ, Kondo S, Yanagisawa N, et al. Probiotics in the treatment of Japanese cedar pollinosis: A double-blind placebo-controlled trial. Clin Exp Allergy 2006; 36(11): 1425-35.
[http://dx.doi.org/10.1111/j.1365-2222.2006.02575.x] [PMID: 17083353]
[121]
Xiao JZ, Kondo S, Yanagisawa N, et al. Effect of probiotic Bifidobacterium longum BB536 [corrected] in relieving clinical symptoms and modulating plasma cytokine levels of Japanese cedar pollinosis during the pollen season. A randomized double blind, placebo-controlled trial. J Investig Allergol Clin Immunol 2006; 16(2): 86-93.
[PMID: 16689181]
[122]
Morita H, He F, Kawase M, et al. Preliminary human study for possible alteration of serum immunoglobulin E production in perennial allergic rhinitis with fermented milk prepared with Lactobacillus gasseri TMC0356. Microbiol Immunol 2006; 50(9): 701-6.
[http://dx.doi.org/10.1111/j.1348-0421.2006.tb03842.x] [PMID: 16985291]
[123]
Xiao J, Kondo S, Takahashi N, et al. Changes in plasma TARC levels during Japanese cedar pollen season and relationships with symptom development. Int Arch Allergy Immunol 2007; 144(2): 123-7.
[http://dx.doi.org/10.1159/000103223] [PMID: 17536220]
[124]
Xiao J, Kondo S, Yanagisawa N, et al. Clinical efficacy of probiotic Bifidobacterium longum for the treatment of symptoms of Japanese cedar pollen allergy in subjects evaluated in an environmental exposure unit. Allergol Int 2007; 56(1): 67-75.
[http://dx.doi.org/10.2332/allergolint.O-06-455] [PMID: 17259812]
[125]
Wassenberg J, Nutten S, Audran R, et al. Effect of Lactobacillus paracasei ST11 on a nasal provocation test with grass pollen in allergic rhinitis. Clin Exp Allergy 2011; 41(4): 565-73.
[http://dx.doi.org/10.1111/j.1365-2222.2011.03695.x] [PMID: 21395878]
[126]
Oranje A. Evidence - based pharmacological treatment of atopic dermatitis: An expert opinion and new expectations. Indian J Dermatol 2014; 59(2): 140-2.
[http://dx.doi.org/10.4103/0019-5154.127673] [PMID: 24700931]
[127]
Wang IJ, Wang JY. Children with atopic dermatitis show clinical improvement after Lactobacillus exposure. Clin Exp Allergy 2015; 45(4): 779-87.
[http://dx.doi.org/10.1111/cea.12489] [PMID: 25600169]
[128]
Yang HJ, Min TK, Lee HW, Pyun BY. Efficacy of probiotic therapy on atopic dermatitis in children: A randomized, double-blind, placebo-controlled trial. Allergy Asthma Immunol Res 2014; 6(3): 208-15.
[http://dx.doi.org/10.4168/aair.2014.6.3.208] [PMID: 24843795]
[129]
Baquerizo Nole KL, Yim E, Keri JE. Probiotics and prebiotics in dermatology. J Am Acad Dermatol 2014; 71(4): 814-21.
[http://dx.doi.org/10.1016/j.jaad.2014.04.050] [PMID: 24906613]
[130]
Matsumoto M. Antipruritic effects of the probiotic strain LKM512 in adults with atopic dermatitis. Annals Aller, Asthma Immunol 2014; 113(2): 209-16.
[http://dx.doi.org/10.1016/j.anai.2014.05.002]
[131]
Kumar S, Mahajan BB, Kamra N. Future perspective of probiotics in dermatology: An old wine in new bottle. Dermatol Online J 2014; 20(9): 13030/qt8br333fc.
[http://dx.doi.org/10.5070/D3209023918] [PMID: 25244173]
[132]
Kalliomäki M, Salminen S, Arvilommi H, Kero P, Koskinen P, Isolauri E. Probiotics in primary prevention of atopic disease: A randomised placebo-controlled trial. Lancet 2001; 357(9262): 1076-9.
[http://dx.doi.org/10.1016/S0140-6736(00)04259-8] [PMID: 11297958]
[133]
Kalliomäki M, Salminen S, Poussa T, Arvilommi H, Isolauri E. Probiotics and prevention of atopic disease: 4-year follow-up of a randomised placebo-controlled trial. Lancet 2003; 361(9372): 1869-71.
[http://dx.doi.org/10.1016/S0140-6736(03)13490-3] [PMID: 12788576]
[134]
Kalliomäki M, Salminen S, Poussa T, Isolauri E. Probiotics during the first 7 years of life: A cumulative risk reduction of eczema in a randomized, placebo-controlled trial. J Allergy Clin Immunol 2007; 119(4): 1019-21.
[http://dx.doi.org/10.1016/j.jaci.2006.12.608] [PMID: 17289135]
[135]
Abrahamsson TR, Jakobsson T, Böttcher MF, et al. Probiotics in prevention of IgE-associated eczema: A double-blind, randomized, placebo-controlled trial. J Allergy Clin Immunol 2007; 119(5): 1174-80.
[http://dx.doi.org/10.1016/j.jaci.2007.01.007] [PMID: 17349686]
[136]
Kukkonen K, Savilahti E, Haahtela T, et al. Probiotics and prebiotic galacto-oligosaccharides in the prevention of allergic diseases: A randomized, double-blind, placebo-controlled trial. J Allergy Clin Immunol 2007; 119(1): 192-8.
[http://dx.doi.org/10.1016/j.jaci.2006.09.009] [PMID: 17208601]
[137]
Roessler A, Friedrich U, Vogelsang H, et al. The immune system in healthy adults and patients with atopic dermatitis seems to be affected differently by a probiotic intervention. Clin Exp Allergy 2008; 38(1): 93-102.
[PMID: 18028460]
[138]
Viljanen M, Savilahti E, Haahtela T, et al. Probiotics in the treatment of atopic eczema/dermatitis syndrome in infants: A double-blind placebo-controlled trial. Allergy 2005; 60(4): 494-500.
[http://dx.doi.org/10.1111/j.1398-9995.2004.00514.x] [PMID: 15727582]
[139]
Ferreira CM. The central role of the gut microbiota in chronic inflammatory diseases. J Immunol Res 2014; 2014: 689492.
[http://dx.doi.org/10.1155/2014/689492]
[140]
Sadrifar S, Abbasi-Dokht T, Forouzandeh S, et al. Immunomodulatory effects of probiotic supplementation in patients with asthma: A randomized, double-blind, placebo-controlled trial. Allergy Asthma Clin Immunol 2023; 19(1): 1-10.
[http://dx.doi.org/10.1186/s13223-022-00753-4] [PMID: 36593510]
[141]
Azad MB, Coneys JG, Kozyrskyj AL, et al. Probiotic supplementation during pregnancy or infancy for the prevention of asthma and wheeze: Systematic review and meta-analysis. BMJ 2013; 347(dec04 12): f6471.
[http://dx.doi.org/10.1136/bmj.f6471] [PMID: 24304677]
[142]
Lin J, Zhang Y, He C, Dai J. Probiotics supplementation in children with asthma: A systematic review and meta-analysis. J Paediatr Child Health 2018; 54(9): 953-61.
[http://dx.doi.org/10.1111/jpc.14126] [PMID: 30051941]
[143]
Wei X, Jiang P, Liu J, Sun R, Zhu L. Association between probiotic supplementation and asthma incidence in infants: A meta-analysis of randomized controlled trials. J Asthma 2020; 57(2): 167-78.
[http://dx.doi.org/10.1080/02770903.2018.1561893] [PMID: 30656984]
[144]
Wawryk-Gawda E, Markut-Miotła E, Emeryk A. Postnatal probiotics administration does not prevent asthma in children, but using prebiotics or synbiotics may be effective potential strategies to decrease the frequency of asthma in high-risk children - A meta-analysis of clinical trials. Allergol Immunopathol 2021; 49(4): 4-14.
[http://dx.doi.org/10.15586/aei.v49i4.69] [PMID: 34224213]
[145]
Dwivedi M, Kumar P, Laddha NC, Kemp EH. Induction of regulatory T cells: A role for probiotics and prebiotics to suppress autoimmunity. Autoimmun Rev 2016; 15(4): 379-92.
[http://dx.doi.org/10.1016/j.autrev.2016.01.002] [PMID: 26774011]
[146]
Li KL, Wang BZ, Li ZP, Li YL, Liang JJ. Alterations of intestinal flora and the effects of probiotics in children with recurrent respiratory tract infection. World J Pediatr 2019; 15(3): 255-61.
[http://dx.doi.org/10.1007/s12519-019-00248-0] [PMID: 31020541]
[147]
Xiao L, Gong C, Ding Y, et al. Probiotics maintain intestinal secretory immunoglobulin A levels in healthy formula-fed infants: A randomised, double-blind, placebo-controlled study. Benef Microbes 2019; 10(7): 729-39.
[http://dx.doi.org/10.3920/BM2019.0025] [PMID: 31965842]
[148]
Sainz T, Gosalbes MJ, Talavera A, et al. Effect of a nutritional intervention on the intestinal microbiota of vertically HIV-infected children: The pediabiota study. Nutrients 2020; 12(7): 2112.
[http://dx.doi.org/10.3390/nu12072112] [PMID: 32708743]
[149]
Horne RG, Freedman SB, Johnson-Henry KC, et al. Intestinal microbial composition of children in a randomized controlled trial of probiotics to treat acute gastroenteritis. Front Cell Infect Microbiol 2022; 12: 883163.
[http://dx.doi.org/10.3389/fcimb.2022.883163] [PMID: 35774405]
[150]
Zhang L, Xu Y, Li H, Li B, Duan G, Zhu C. The role of probiotics in children with autism spectrum disorders: A study protocol for a randomised controlled trial. PLoS One 2022; 17(2): e0263109.
[http://dx.doi.org/10.1371/journal.pone.0263109] [PMID: 35202432]
[151]
Ahmed M, Prasad J, Gill H, Stevenson L, Gopal P. Impact of consumption of different levels of Bifidobacterium lactis HN019 on the intestinal microflora of elderly human subjects. J Nutr Health Aging 2007; 11(1): 26-31.
[PMID: 17315077]
[152]
Childs CE, Röytiö H, Alhoniemi E, et al. Xylo-oligosaccharides alone or in synbiotic combination with Bifidobacterium animalis subsp. lactis induce bifidogenesis and modulate markers of immune function in healthy adults: A double-blind, placebo-controlled, randomised, factorial cross-over study. Br J Nutr 2014; 111(11): 1945-56.
[http://dx.doi.org/10.1017/S0007114513004261] [PMID: 24661576]
[153]
Toscano M, De Grandi R, Stronati L, De Vecchi E, Drago L. Effect of Lactobacillus rhamnosus HN001 and Bifidobacterium longum BB536 on the healthy gut microbiota composition at phyla and species level: A preliminary study. World J Gastroenterol 2017; 23(15): 2696-704.
[http://dx.doi.org/10.3748/wjg.v23.i15.2696] [PMID: 28487606]
[154]
Kirpich IA, Solovieva NV, Leikhter SN, et al. Probiotics restore bowel flora and improve liver enzymes in human alcohol-induced liver injury: A pilot study. Alcohol 2008; 42(8): 675-82.
[http://dx.doi.org/10.1016/j.alcohol.2008.08.006] [PMID: 19038698]
[155]
Yoon JY, Cha JM, Oh JK, et al. Probiotics ameliorate stool consistency in patients with chronic constipation: A randomized, double-blind, placebo-controlled study. Dig Dis Sci 2018; 63(10): 2754-64.
[http://dx.doi.org/10.1007/s10620-018-5139-8] [PMID: 29876777]
[156]
Everard A, Matamoros S, Geurts L, Delzenne NM, Cani PD. Saccharomyces boulardii administration changes gut microbiota and reduces hepatic steatosis, low-grade inflammation, and fat mass in obese and type 2 diabetic db/db mice. MBio 2014; 5(3): e01011-4.
[http://dx.doi.org/10.1128/mBio.01011-14] [PMID: 24917595]
[157]
Song H, Wang W, Shen B, et al. Pretreatment with probiotic Bifico ameliorates colitis-associated cancer in mice: Transcriptome and gut flora profiling. Cancer Sci 2018; 109(3): 666-77.
[http://dx.doi.org/10.1111/cas.13497] [PMID: 29288512]
[158]
Zaylaa M, Alard J, Kassaa IA, et al. Autophagy: A novel mechanism involved in the anti-inflammatory abilities of probiotics. Cell Physiol Biochem 2019; 53(5): 774-93.
[http://dx.doi.org/10.33594/000000172] [PMID: 31647207]
[159]
Kwon HK, Lee CG, So JS, et al. Generation of regulatory dendritic cells and CD4 + Foxp3 + T cells by probiotics administration suppresses immune disorders. Proc Natl Acad Sci 2010; 107(5): 2159-64.
[http://dx.doi.org/10.1073/pnas.0904055107] [PMID: 20080669]
[160]
Sakai F, Hosoya T, Ono-Ohmachi A, et al. Lactobacillus gasseri SBT2055 induces TGF-β expression in dendritic cells and activates TLR2 signal to produce IgA in the small intestine. PLoS One 2014; 9(8): e105370.
[http://dx.doi.org/10.1371/journal.pone.0105370] [PMID: 25144744]
[161]
Damaceno QS, Souza JP, Nicoli JR, et al. Evaluation of potential probiotics isolated from human milk and colostrum. Probiotics Antimicrob Proteins 2017; 9(4): 371-9.
[http://dx.doi.org/10.1007/s12602-017-9270-1] [PMID: 28374172]

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy